Dr. Brian Cole Leads 1st US Study of Stem Cell Treatment for Knee Cartilage Damage

Brian Cole, MD, an orthopedic surgeon at Rush University Medical Center, is the principle investigator on the first clinical study of Cartistem in the United States, according to a News-Medical report.

Advertisement

Cartistem is a stem cell therapy designed to repair knee cartilage. It is manufactured from mesenchymal stem cells, according to the report, and mixed with hyaluronan. The two-year study plans to enroll 12 participants.

Dr. Cole is the head of Rush’s Cartilage Restoration Center.

More Articles on Orthopedic Surgery:

8 Ideas for Orthopedic Practices to Improve Their Bottom Line

102 Surgeons Focused on Spine Surgery

3B Orthopaedics Surgeons Join Aria Health

At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.

Advertisement

Next Up in Uncategorized

Advertisement

Comments are closed.